MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 44 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $287,212 | +22.1% | 9,089 | 0.0% | 0.02% | +20.0% |
| Q2 2023 | $235,132 | -94.8% | 9,089 | -96.5% | 0.02% | -94.2% |
| Q2 2021 | $4,486,000 | -52.5% | 259,465 | -45.5% | 0.26% | -54.4% |
| Q1 2021 | $9,442,000 | +18.9% | 476,401 | +4.7% | 0.57% | +20.1% |
| Q4 2020 | $7,944,000 | +28.3% | 454,974 | +41.6% | 0.47% | +3.1% |
| Q3 2020 | $6,191,000 | -41.3% | 321,252 | -40.7% | 0.46% | -31.0% |
| Q2 2020 | $10,541,000 | +79.9% | 541,701 | +29.4% | 0.66% | +22.7% |
| Q1 2020 | $5,860,000 | – | 418,589 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |